OraSure Technologies | OSUR - Loan Capital


OraSure Technologies reported $100K in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Agilent USD 3.05B 0 Dec/2025
AngioDynamics USD 5.6M 100K Sep/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Bio Techne USD 260M 40M Dec/2025
Bio-Rad Laboratories USD 1.2B 300K Dec/2025
Bruker USD 1.85B 131.7M Dec/2025
Cerus USD 64.86M 22K Dec/2024
Charles River Laboratories USD 2.14B 49.09M Dec/2025
Danaher USD 18.42B 1.58B Dec/2025
Dentsply International USD 2.02B 2M Dec/2025
Dexcom USD 1.24B 53.6M Dec/2025
Illumina USD 1.49B 496M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Mesa Laboratories USD 104.2M 104.3M Sep/2024
Mettler Toledo International USD 2.09B 58.01M Dec/2025
Myriad Genetics USD 119.9M 400K Dec/2025
OraSure Technologies USD 100K 17K Dec/2025
Quidel USD 2.47B 2.47B Dec/2025
Repligen USD 542.21M 4.29M Dec/2025
Revvity USD 2.63B 543K Dec/2025
STAAR Surgical USD 42K 42K Dec/2023
Thermo Fisher Scientific USD 35.85B 4B Dec/2025
Trinity Biotech USD 114.86M 4.81M Sep/2025
Waters USD 1.41B 460.24M Dec/2025